You are here

Role of membrane damaging effector proteins in innate immune cell-mediated tissue injury

Lytic forms of programmed cell death, pyroptosis and necroptosis, play an integral role in driving innate inflammatory responses and tissue damage in a range of inflammatory diseases (reviewed in Lawlor KE Immunity 2024 57:429). However, the specific role of the membrane-damaging pyroptotic Gasdermin (GSDMD & GSDME) and necroptotic Mixed lineage kinase domain-like (MLKL) effector proteins are ill-defined. Moreover, there is very little known about the role of the downstream plasma membrane rupture molecule Ninjurin-1 (NINJ1) in models of inflammatory disease. This project will use mice deficient in these key effector proteins, and inhibitory drugs, to explore their role in renal and cardiac tissue damage. This project will offer the opportunity to be trained in a range of techniques, including preclinical human/mouse models of disease, primary cell culture, western blotting, specialised cell death assays, immunofluorescence, qPCR, ELISA, tissue analysis, histopathology, flow cytometry and CRISPR/Cas9 gene editing.
Essential criteria: 
Minimum entry requirements can be found here:
Cell death, Cell signalling pathways, Inflammasomes, Innate immunity, tissue damage
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options 
Masters by research
Time commitment 
Top-up scholarship funding available 
Physical location 
Monash Health Translation Precinct (Monash Medical Centre)
Timothy Gottschalk

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.